Functional and Therapeutic Relevance of CD56(NCAM) Expression in Multiple Myeloma

被引：0
|
作者：
Gattenlohner, S.
Mottok, A.
Stuhmer, T.
Bargou, R.
Einsele, H.
Muller-Hermelink, H-K
机构：
[1] Med Univ Graz, Inst Pathol, Graz, Austria
[2] Univ Wurzburg, Inst Pathol, D-97070 Wurzburg, Germany
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1263
引用
收藏
页码：297A / 297A
页数：1
相关论文
共 50 条
  • [41] The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients
    Ceran, Funda
    Falay, Mesude
    Dagdas, Simten
    Ozet, Gulsum
    TURKISH JOURNAL OF HEMATOLOGY, 2017, 34 (03) : 226 - 232
  • [42] INCREASED EXPRESSION OF CD56 AND HLA/DR ANTIGENS IN CD2+ CELLS FROM MULTIPLE-MYELOMA PATIENTS
    LAPENA, P
    PRIETO, A
    GARCIASUAREZ, J
    REYES, E
    SANMIGUEL, J
    JORDA, J
    ALVAREZMON, M
    AMERICAN JOURNAL OF HEMATOLOGY, 1994, 46 (02) : 158 - 159
  • [43] CD56 expression of mycloid neoplasms
    Sakai, N
    Saito, Y
    Uzuka, Y
    7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION, 2002, : 185 - 188
  • [44] THE ROLE OF EXPRESSION CD56 ON BONE MARROW PLASMA CELLS AND EXTRAMEDULLARY PLASMA CELLS IN PATIENTS WITH MULTIPLE MYELOMA
    Firsova, M.
    Mendeleeva, L.
    Kovrigina, A.
    Soloviev, M.
    Pokrovskaya, O.
    Nareyko, M.
    Kuzmina, L.
    Savchenko, V.
    HAEMATOLOGICA, 2017, 102 : 795 - 796
  • [45] Targeting Aberrant Ncam (neural cell adhesion molecule; CD56) Expression in Acute Myeloid Leukemia
    Sasca, Daniel
    Schueler, Andrea
    Szybinski, Jakub
    Kriege, Oliver
    Kunz, Kerstin
    Fehr, Eva Marie
    Haehnel, Patricia
    Gebhardt, Wolf Henning
    Reid, Gerge
    Theobald, Matthias
    Bullinger, Lars
    Kindler, Thomas
    BLOOD, 2015, 126 (23)
  • [46] Targeting aberrant NCAM (neural cell adhesion molecule; CD56) expression in acute myeloid leukemia
    Sasca, D.
    Schueler, A.
    Kriege, O.
    Kunz, K.
    Szybinski, J.
    Fehr, E-M
    Haehnel, P. S.
    Gebhardt, W. H.
    Reid, G.
    Theobald, M.
    Bullinger, L.
    Kindler, T.
    Oncology Research and Treatment, 2015, 38 : 8 - 8
  • [47] TARGETING ABERRANT NCAM (NEURAL CELL ADHESION MOLECULE; CD56) EXPRESSION IN ACUTE MYELOID LEUKEMIA
    Sasca, D.
    Kriege, O.
    Kunz, K.
    Schueler, A.
    Szybinski, J.
    Fehr, E. M.
    Haehnel, P.
    Theobald, M.
    Bullinger, L.
    Kindler, T.
    HAEMATOLOGICA, 2015, 100 : 34 - 35
  • [48] Prognostic significance of surface markers expressed in multiple myeloma: CD56 and other antigens
    Sahara, N
    Takeshita, A
    LEUKEMIA & LYMPHOMA, 2004, 45 (01) : 61 - 65
  • [49] The clinical significance of CD49e and CD56 for multiple myeloma in the novel agents era
    Okura, Miyuki
    Ida, Naoko
    Yamauchi, Takahiro
    MEDICAL ONCOLOGY, 2020, 37 (11)
  • [50] EXPRESSION OF THE NEURAL CELL-ADHESION MOLECULE (CD56) BY HUMAN MYELOMA CELLS
    DRACH, J
    GATTRINGER, C
    HUBER, H
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1991, 83 (03): : 418 - 422
12345